# CTO Realty Growth, Inc.: financial statements, quarterly

CTO · NYSE · CIK 23795 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cto.md) · [Financials](/companies/cto/financials.md) · [Filings](/companies/cto/filings.md) · [Insiders](/companies/cto/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cto/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [29.9 d](/filings/0001104659-26-017560.md) | [28.1](/filings/0001558370-25-006109.md) | [28.8](/filings/0001558370-25-009742.md) | [31.8](/filings/0001104659-25-103192.md) | [35.7 d](/filings/0001104659-26-017560.md) | [35.8](/filings/0001104659-26-050378.md) | [37.6](/filings/0001104659-26-087549.md) | [37.8](/filings/0001104659-26-119165.md) | [38.3 d](/filings/0001104659-26-017560.md) | [41.2](/filings/0001104659-26-050378.md) | [43.8](/filings/0001104659-26-087549.md) | [46.9](/filings/0001104659-26-119165.md) |
| Cost of revenue | $m | [8.4 d](/filings/0001104659-26-017560.md) | [7.6](/filings/0001558370-25-006109.md) | [8.3](/filings/0001558370-25-009742.md) | [8.2](/filings/0001104659-25-103192.md) | [9.2 d](/filings/0001104659-26-017560.md) | [8.9](/filings/0001104659-26-050378.md) | [10.2](/filings/0001104659-26-087549.md) | [9.3](/filings/0001104659-26-119165.md) | [9.6 d](/filings/0001104659-26-017560.md) | [10.2](/filings/0001104659-26-050378.md) | [11.1](/filings/0001104659-26-087549.md) | [11.6](/filings/0001104659-26-119165.md) |
| Gross profit | $m | not reported | [20.6](/filings/0001558370-25-006109.md) | [20.5](/filings/0001558370-25-009742.md) | [23.6](/filings/0001104659-25-103192.md) | [26.6 d](/filings/0001104659-26-017560.md) | [26.9](/filings/0001104659-26-050378.md) | [27.5](/filings/0001104659-26-087549.md) | [28.5](/filings/0001104659-26-119165.md) | [28.8 d](/filings/0001104659-26-017560.md) | [31.0](/filings/0001104659-26-050378.md) | [32.7](/filings/0001104659-26-087549.md) | [35.3](/filings/0001104659-26-119165.md) |
| Operating income | $m | [10.2 d](/filings/0001104659-26-017560.md) | [14.5](/filings/0001558370-25-006109.md) | [5.4](/filings/0001558370-25-009742.md) | [5.0](/filings/0001104659-25-103192.md) | [(7.3) d](/filings/0001104659-26-017560.md) | [7.9](/filings/0001104659-26-050378.md) | [(12.7)](/filings/0001104659-26-087549.md) | [10.0](/filings/0001104659-26-119165.md) | [28.8 d](/filings/0001104659-26-017560.md) | [10.3](/filings/0001104659-26-050378.md) | [13.3](/filings/0001104659-26-087549.md) | [11.6](/filings/0001104659-26-119165.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2 d](/filings/0001104659-26-017560.md) | [(0.1)](/filings/0001558370-25-006109.md) | [0.1](/filings/0001558370-25-009742.md) | [0.1](/filings/0001104659-25-103192.md) | [(0.4) d](/filings/0001104659-26-017560.md) | [0.1](/filings/0001104659-26-050378.md) | [0.2](/filings/0001104659-26-087549.md) | [0.1](/filings/0001104659-26-119165.md) | [0.1 d](/filings/0001104659-26-017560.md) | [0.1](/filings/0001104659-26-050378.md) | [1.1](/filings/0001104659-26-087549.md) | [(0.6)](/filings/0001104659-26-119165.md) |
| Net income | $m | [7.0 d](/filings/0001104659-26-017560.md) | [5.8](/filings/0001558370-25-006109.md) | [1.2](/filings/0001558370-25-009742.md) | [6.2](/filings/0001104659-25-103192.md) | [(15.2) d](/filings/0001104659-26-017560.md) | [2.3](/filings/0001104659-26-050378.md) | [(23.4)](/filings/0001104659-26-087549.md) | [2.9](/filings/0001104659-26-119165.md) | [28.3 d](/filings/0001104659-26-017560.md) | [6.2](/filings/0001104659-26-050378.md) | [15.1](/filings/0001104659-26-087549.md) | [(5.2)](/filings/0001104659-26-119165.md) |
| Diluted EPS | $ per share | not reported | [0.20](/filings/0001558370-25-006109.md) | [(0.03)](/filings/0001558370-25-009742.md) | [0.17](/filings/0001104659-25-103192.md) | not reported | [0.01](/filings/0001104659-26-050378.md) | [(0.77)](/filings/0001104659-26-087549.md) | [0.03](/filings/0001104659-26-119165.md) | not reported | [0.13](/filings/0001104659-26-050378.md) | [0.38](/filings/0001104659-26-087549.md) | [(0.19)](/filings/0001104659-26-119165.md) |
| Basic EPS | $ per share | not reported | [0.21](/filings/0001558370-25-006109.md) | [(0.03)](/filings/0001558370-25-009742.md) | [0.17](/filings/0001104659-25-103192.md) | not reported | [0.01](/filings/0001104659-26-050378.md) | [(0.77)](/filings/0001104659-26-087549.md) | [0.03](/filings/0001104659-26-119165.md) | not reported | [0.13](/filings/0001104659-26-050378.md) | [0.38](/filings/0001104659-26-087549.md) | [(0.19)](/filings/0001104659-26-119165.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [10.2](/filings/0001104659-26-017560.md) | [6.8](/filings/0001558370-25-006109.md) | [4.8](/filings/0001558370-25-009742.md) | [8.2](/filings/0001104659-25-103192.md) | [9.0](/filings/0001104659-26-017560.md) | [8.4](/filings/0001104659-26-050378.md) | [8.6](/filings/0001104659-26-087549.md) | [9.3](/filings/0001104659-26-119165.md) | [6.5](/filings/0001104659-26-119165.md) | [8.3](/filings/0001104659-26-050378.md) | [8.1](/filings/0001104659-26-087549.md) | [8.8](/filings/0001104659-26-119165.md) |
| Total assets | $m | [990](/filings/0001558370-25-001229.md) | [1,041](/filings/0001558370-24-006550.md) | [1,010](/filings/0001558370-24-010187.md) | [1,176](/filings/0001558370-24-013628.md) | [1,182](/filings/0001104659-26-017560.md) | [1,244](/filings/0001558370-25-006109.md) | [1,233](/filings/0001558370-25-009742.md) | [1,222](/filings/0001104659-25-103192.md) | [1,264](/filings/0001104659-26-119165.md) | [1,300](/filings/0001104659-26-050378.md) | [1,406](/filings/0001104659-26-087549.md) | [1,495](/filings/0001104659-26-119165.md) |
| Total liabilities | $m | [532](/filings/0001558370-25-001229.md) | [579](/filings/0001558370-24-006550.md) | [518](/filings/0001558370-24-010187.md) | [580](/filings/0001558370-24-013628.md) | [569](/filings/0001104659-26-017560.md) | [650](/filings/0001558370-25-006109.md) | [659](/filings/0001558370-25-009742.md) | [665](/filings/0001104659-25-103192.md) | [697](/filings/0001104659-26-119165.md) | [724](/filings/0001104659-26-050378.md) | [743](/filings/0001104659-26-087549.md) | [814](/filings/0001104659-26-119165.md) |
| Long-term debt | $m | [495](/filings/0001558370-25-001229.md) | [542](/filings/0001558370-24-006550.md) | [483](/filings/0001558370-24-010187.md) | [527](/filings/0001558370-24-013628.md) | [519](/filings/0001104659-26-017560.md) | [602](/filings/0001558370-25-006109.md) | [605](/filings/0001558370-25-009742.md) | [604](/filings/0001104659-25-103192.md) | [616](/filings/0001104659-26-119165.md) | [650](/filings/0001104659-26-050378.md) | [659](/filings/0001104659-26-087549.md) | [718](/filings/0001104659-26-119165.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [458](/filings/0001558370-25-001229.md) | [462](/filings/0001558370-24-006550.md) | [492](/filings/0001558370-24-010187.md) | [596](/filings/0001558370-24-013628.md) | [613](/filings/0001104659-26-017560.md) | [594](/filings/0001558370-25-006109.md) | [574](/filings/0001558370-25-009742.md) | [557](/filings/0001104659-25-103192.md) | [567](/filings/0001104659-26-119165.md) | [575](/filings/0001104659-26-050378.md) | [663](/filings/0001104659-26-087549.md) | [681](/filings/0001104659-26-119165.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.4 d](/filings/0001104659-26-017560.md) | [11.8](/filings/0001558370-25-006109.md) | [12.9 d](/filings/0001558370-25-009742.md) | [21.2 d](/filings/0001104659-25-103192.md) | [14.0 d](/filings/0001104659-26-017560.md) | [10.3](/filings/0001104659-26-050378.md) | [17.1 d](/filings/0001104659-26-087549.md) | [30.8 d](/filings/0001104659-26-119165.md) | [6.3 d](/filings/0001104659-26-017560.md) | [14.6](/filings/0001104659-26-050378.md) | [20.0 d](/filings/0001104659-26-087549.md) | [24.6 d](/filings/0001104659-26-119165.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [8.5 d](/filings/0001104659-26-017560.md) | [8.6](/filings/0001558370-25-006109.md) | [8.7 d](/filings/0001558370-25-009742.md) | [11.0 d](/filings/0001104659-25-103192.md) | [11.9 d](/filings/0001104659-26-017560.md) | [12.0](/filings/0001104659-26-050378.md) | [12.0](/filings/0001104659-26-087549.md) | [12.4](/filings/0001104659-26-119165.md) | [12.2 d](/filings/0001104659-26-017560.md) | [12.6](/filings/0001104659-26-050378.md) | [13.9](/filings/0001104659-26-087549.md) | [14.6](/filings/0001104659-26-119165.md) |
| Share repurchases | $m | not reported | [0.7](/filings/0001558370-25-006109.md) | [0.0 d](/filings/0001558370-25-009742.md) | [0.0 d](/filings/0001104659-25-103192.md) | [0.0 d](/filings/0001104659-26-017560.md) | not reported | not reported | [4.3 d](/filings/0001104659-26-119165.md) | [5.0 d](/filings/0001104659-26-017560.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.7](/filings/0001558370-24-006550.md) | [22.5](/filings/0001558370-24-010187.md) | [22.5](/filings/0001558370-24-013628.md) | [26.1](/filings/0001558370-25-006109.md) | [22.8](/filings/0001558370-25-009742.md) | [25.5](/filings/0001104659-25-103192.md) | [31.6](/filings/0001104659-26-050378.md) | [32.7](/filings/0001104659-26-087549.md) | [32.7](/filings/0001104659-26-119165.md) | [32.5](/filings/0001104659-26-050378.md) | [35.0](/filings/0001104659-26-087549.md) | [37.6](/filings/0001104659-26-119165.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,760,232 at 2026-10-20, from the cover of the [10-Q filed 2026-10-27](/filings/0001104659-26-119165.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 19:10 ET. No prices; not investment advice.